Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg Exporter

Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg Exporter in India – Healthy Inc

Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg Exporter product packaging

Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg | Exporter

Product image for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg Exporter; regulatory dossiers & international shipping.

Product Information

Generic NameAluminium Hydroxide & Magnesium Trisilicate
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaNFI
Product TypeTablet
CategoryAntiulcer drugs – Antacid
SubcategoryAntacid
Active IngredientAluminium Hydroxide & Magnesium Trisilicate
Strength120 mg + 250 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAntiulcer drugs – Antacid

Medicine Details & Safety

Short DescriptionHealthy Inc invites international procurement enquiries for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.
Approved Uses / Indications1. Symptomatic relief and healing of erosive gastroesophageal reflux disease (GERD). 2. Treatment of gastric ulcers, duodenal ulcers, and NSAID-associated mucosal injury.
Full Description

Healthy Inc invites international procurement enquiries for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.

Product technical specifications

Generic nameAluminium Hydroxide & Magnesium Trisilicate
CompositionAluminium Hydroxide & Magnesium Trisilicate
Strength120 mg + 250 mg
CategoryAntiulcer drugs – Antacid
PharmacopoeiaNFI
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Export regulatory and dossier readiness

Identify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.

Climatic zone stability and export artwork

For Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.

Global logistics and trade terms

Specify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.

International buyer requirements

Enquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations.
Dosage InstructionsAdminister orally 30 to 60 minutes before morning meals (or as prescribed for antacids, after meals and at bedtime). Swallow whole with water; do not crush or chew enteric-coated tablets.
Side EffectsCommon: Headache, diarrhea, constipation, abdominal discomfort, nausea. Uncommon: Flatulence, dry mouth, dizziness, transient transaminase elevation. Rare: Hypomagnesemia, Clostridioides difficile-associated diarrhea, subacute cutaneous lupus.
Warnings and PrecautionsMasking Malignancy: Symptomatic relief does not preclude presence of gastric malignancy; perform diagnostic workup if alarm symptoms exist. Long-Term Bone Density: Extended chronic use may slightly elevate risk of osteoporosis-related fractures; ensure adequate calcium and vitamin D intake.
Contraindications1. Known hypersensitivity to Aluminium Hydroxide & Magnesium Trisilicate or substituted benzimidazoles / antacids.
2. Severe electrolyte imbalances (for magnesium/aluminum antacids in renal failure).
3. Concurrent administration with rilpivirine-containing products.
Drug Interactions1. pH-Dependent Bioavailability Drugs (Ketoconazole, Itraconazole, Iron Salts): Reduced absorption due to elevated gastric pH.
2. Clopidogrel: Potential attenuation of antiplatelet activation by certain proton pump inhibitors.
3. Digoxin & Methotrexate: Elevated serum concentrations requiring dosage monitoring.

Frequently Asked Questions

QuestionAnswer
Which registration documents can be requested for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg?Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review.
Is Zone IVb data available for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg?Request confirmation for the exact formulation and packaging configuration.
Can export artwork be multilingual for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg?Provide the required languages and approved regulatory artwork for review.
Which shipping terms can be discussed for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg?EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement.
How do I obtain an export quotation for Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg?Provide destination country, quantity, documentation requirements and preferred trade terms.

Product Tags

Aluminium Hydroxide & Magnesium Trisilicate Tablets NFI Tablets IP 120 mg + 250 mg ExporterAluminium Hydroxide & Magnesium Trisilicate 120 mg + 250 mgRegulatory Dossiers & International ShippingHealthy Inc

Product Hashtags

#Aluminium#Exporter#PharmaB2B

Related Products

Latest Posts